Research ArticleClinical Investigations
In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195
Eero Rissanen, Jouni Tuisku, Johanna Rokka, Teemu Paavilainen, Riitta Parkkola, Juha O. Rinne and Laura Airas
Journal of Nuclear Medicine June 2014, 55 (6) 939-944; DOI: https://doi.org/10.2967/jnumed.113.131698
Eero Rissanen
1Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland
2Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland
Jouni Tuisku
1Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland
Johanna Rokka
1Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland
Teemu Paavilainen
3Medical Imaging Centre of Southwest Finland, Turku University Hospital and University of Turku, Turku, Finland; and
Riitta Parkkola
1Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland
4Department of Radiology, University Hospital of Tampere, Tampere, Finland
Juha O. Rinne
1Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland
Laura Airas
2Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 6
June 1, 2014
In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195
Eero Rissanen, Jouni Tuisku, Johanna Rokka, Teemu Paavilainen, Riitta Parkkola, Juha O. Rinne, Laura Airas
Journal of Nuclear Medicine Jun 2014, 55 (6) 939-944; DOI: 10.2967/jnumed.113.131698
In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195
Eero Rissanen, Jouni Tuisku, Johanna Rokka, Teemu Paavilainen, Riitta Parkkola, Juha O. Rinne, Laura Airas
Journal of Nuclear Medicine Jun 2014, 55 (6) 939-944; DOI: 10.2967/jnumed.113.131698
Jump to section
Related Articles
Cited By...
- Etifoxine inhibits NLRP3 inflammasome activity in human and murine myeloid cells
- Association of serum neurofilament light with microglial activation in multiple sclerosis
- Multimodal diagnostics in multiple sclerosis: predicting disability and conversion from relapsing-remitting to secondary progressive disease course - protocol for systematic review and meta-analysis
- Association of serum neurofilament light with microglial activation in multiple sclerosis
- Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis: New Insights
- Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis
- Insights into smouldering MS brain pathology with multimodal diffusion tensor and PET imaging
- Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis
- Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging
- Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study
- Natalizumab treatment reduces microglial activation in the white matter of the MS brain
- Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function
- Microglial activation, white matter tract damage, and disability in MS
- Microglial Phenotypes and Functions in Multiple Sclerosis
- Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis
- 11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis
- In Vivo PET Imaging Demonstrates Diminished Microglial Activation After Fingolimod Treatment in an Animal Model of Multiple Sclerosis